Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Sequencing aids management of young cancer patients

    Author:
    HT Staff
    Publish date: September 2, 2015

    patient and her father Photo by Rhoda Baer Exome and transcriptome sequencing results can inform the management of young patients with relapsed,...

    • Read More

    News

    Extending DAPT may provide benefit for some, speaker says

    Author:
    HT Staff
    Publish date: September 2, 2015

    LONDON—Extending dual antiplatelet therapy (DAPT) beyond the recommended 12 months after coronary stenting “should be considered” in patients with...

    • Read More

    News

    A new, improved treatment approach for lymphoma?

    Author:
    HT Staff
    Publish date: September 1, 2015

    Researchers believe they have discovered how therapy targeting CD47 harnesses the immune system to fight lymphoma and other cancers. Conducting...

    • Read More

    News

    Research reveals potential target for stent thrombosis

    Author:
    HT Staff
    Publish date: September 1, 2015

    Image by Volker Brinkmann LONDON—Immune cells may represent an important therapeutic target for preventing stent thrombosis, according to...

    • Read More

    News

    Score ‘modestly accurate’ for predicting thromboembolism

    Author:
    HT Staff
    Publish date: September 1, 2015

    Image by Kevin MacKEnzie LONDON—A score used to predict the risk of thromboembolic events, ischemic stroke, and death is only modestly accurate...

    • Read More

    News

    Doc says fatal bleeding with extended DAPT is rare

    Author:
    HT Staff
    Publish date: September 1, 2015

    Photo by Sage Ross LONDON—Fatal bleeding is rare with extended dual antiplatelet therapy (DAPT), according to research presented at the ESC...

    • Read More

    News

    Prolonged TV watching linked to fatal PE

    Author:
    HT Staff
    Publish date: August 31, 2015

    The study, which included more than 86,000 subjects, showed that watching an average of 5 or more hours of TV per day was associated with more...

    • Read More

    News

    Extra education about apixaban may be unnecessary

    Author:
    HT Staff
    Publish date: August 31, 2015

    Photo courtesy of Pfizer and Bristol-Myers Squibb LONDON—An educational program designed to improve adherence to the anticoagulant apixaban...

    • Read More

    News

    Public uninformed about cancer therapies, survey suggests

    Author:
    HT Staff
    Publish date: August 30, 2015

    receiving chemotherapy Photo by Rhoda Baer Results of a new survey suggest many adults in the UK may be uninformed about cancer treatment options...

    • Read More

    News

    Protein may be key in virus, cancer research

    Author:
    HT Staff
    Publish date: August 29, 2015

    Image courtesy of the University of North Carolina Researchers say they have uncovered a viral protein that inhibits cGAS, the principal...

    • Read More

    News

    Retinoids, FAK inhibitors may aid TKIs in treating ALL subtype

    Author:
    HT Staff
    Publish date: August 28, 2015

    and Charles Mullighan Photo courtesy of St.

    • Read More

    News

    Malaria tests underused despite training

    Author:
    HT Staff
    Publish date: August 28, 2015

    Photo courtesy of USAID A study conducted in Nigeria has shown that health providers continue to prescribe malaria medicines inappropriately,...

    • Read More

    News

    Inhibitors can target CML stem cells

    Author:
    HT Staff
    Publish date: August 28, 2015

    Preclinical research has revealed nutrients that support the activity of chronic myelogenous leukemia (CML) stem cells and suggests these...

    • Read More

    News

    Discovery reveals potential for viral cancer treatment

    Author:
    HT Staff
    Publish date: August 28, 2015

    Image by Eric Smith Researchers say they have discovered critical details that explain how a cellular response system tells the difference...

    • Read More

    News

    Drugs don’t play well together in MF

    Author:
    HT Staff
    Publish date: August 27, 2015

    Photo courtesy of the CDC Simultaneous administration of lenalidomide and ruxolitinib is not feasible in patients with myelofibrosis (MF),...

    • Read More

    Pages

    • « first
    • …
    • 159
    • 160
    • 161
    • 162
    • 163
    • 164
    • 165
    • 166
    • 167
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery